The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.
The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.
Practical One-Pot Preparation of Magnesium Di(hetero)aryl- and Magnesium Dialkenylboronates for Suzuki-Miyaura Cross-Coupling Reactions
作者:Benjamin A. Haag、Christoph Sämann、Anukul Jana、Paul Knochel
DOI:10.1002/anie.201103022
日期:2011.8.1
Mg for B: An atom‐economical one‐potsynthesis by direct magnesium insertion in the presence of B(OBu)3 and LiCl allows a broad range of functionalized (hetero)aryl and alkenyl bromides to be converted into magnesium diorganoboronates 2, which undergo Suzuki–Miyauracross‐couplingreactions with various aryl (pseudo)halides (see scheme). Both aryl groups of 2 are transferred and furnish the products
Photosensitized (Electron-Transfer) Deconjugation of 1-Arylcyclohexenes
作者:Dino Mangion、Jamie Kendall、Donald R. Arnold
DOI:10.1021/ol006755s
日期:2001.1.1
series of 1-arylcyclohexenes have been deconjugated to the corresponding 3-arylcyclohexenes via a photosensitizedelectron-transferreaction. The introduction of substituents on the aryl group has provided insight into the underlying mechanism and has defined the scope and limitations of the reaction.
Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders.